UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Validating a Sclera-Based Smartphone Application for Screening Jaundiced Newborns in Ghana

Enweronu-Laryea, Christabel; Leung, Terence; Outlaw, Felix; Brako, Nana Okai; Insaidoo, Genevieve; Hagan-Seneadza, Nana Ayegua; Ani-Amponsah, Mary; ... Meek, Judith; + view all (2022) Validating a Sclera-Based Smartphone Application for Screening Jaundiced Newborns in Ghana. Pediatrics , 150 (1) , Article e2021053600. 10.1542/peds.2021-053600. Green open access

[thumbnail of PEDIATRICS-2021-053600v4-Enweronu-Laryea.pdf]
Preview
Text
PEDIATRICS-2021-053600v4-Enweronu-Laryea.pdf - Accepted Version

Download (230kB) | Preview

Abstract

OBJECTIVES: Reducing the burden of bilirubin-induced neurologic complications in low-resource countries requires reliable and accessible screening tools. We sought to optimize and validate a sclera-based smartphone application, Neonatal Scleral-Conjunctival Bilirubin (neoSCB), for screening neonatal jaundice. METHODS: Using a cross-sectional design, consecutive eligible infants (aged 0–28 days, in the hospital, not critically ill) were enrolled in Ghana from March 2019 to April 2020. Jaundice screening was performed with neoSCB (Samsung Galaxy S8) to quantify SCB and JM-105 (Dräger) for transcutaneous bilirubin (TcB). Screening values were compared with total serum bilirubin (TSB) measured at the point of care. RESULTS: Overall, 724 infants participated in the optimization and validation phases of the study. The analysis for validation included 336 infants with no previous treatment of jaundice. Single neoSCB image captures identified infants with TSB >14.62 mg/dL (250 μmol/L) with reasonably high sensitivity, specificity, and receiver operating characteristic area under the curve at 0.94 (95% confidence interval [CI], 0.91 to 0.97), 0.73 (95% CI, 0.68 to 0.78), and 0.90, respectively. These findings were comparable to the sensitivity and specificity of JM-105 (0.96 [95% CI, 0.90 to 0.99] and 0.81 [95% CI, 0.76 to 0.86], respectively). The TcB/TSB had a larger correlation coefficient (r = 0.93; P < .01) than SCB/TSB (r = 0.78; P < .01). Performance of both devices was lower in infants with previous phototherapy (n = 231). CONCLUSIONS: The diagnostic performance of neoSCB was comparable to JM-105 and is a potential, affordable, contact-free screening tool for neonatal jaundice.

Type: Article
Title: Validating a Sclera-Based Smartphone Application for Screening Jaundiced Newborns in Ghana
Open access status: An open access version is available from UCL Discovery
DOI: 10.1542/peds.2021-053600
Publisher version: https://doi.org/10.1542/peds.2021-053600
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Med Phys and Biomedical Eng
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10149705
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item